ProPhase Labs, Inc. (PRPH)
NASDAQ: PRPH · Real-Time Price · USD
0.4222
-0.0121 (-2.79%)
At close: Sep 17, 2025, 4:00 PM EDT
0.4296
+0.0074 (1.75%)
After-hours: Sep 17, 2025, 7:58 PM EDT
ProPhase Labs Employees
ProPhase Labs had 96 employees as of December 31, 2024. The number of employees decreased by 17 or -15.04% compared to the previous year.
Employees
96
Change (1Y)
-17
Growth (1Y)
-15.04%
Revenue / Employee
$58,208
Profits / Employee
-$431,792
Market Cap
17.54M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 96 | -17 | -15.04% |
| Dec 31, 2023 | 113 | -16 | -12.40% |
| Dec 31, 2022 | 129 | 0 | - |
| Dec 31, 2021 | 129 | 34 | 35.79% |
| Dec 31, 2020 | 95 | 45 | 90.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
PRPH News
- 5 days ago - ProPhase Labs Stockholders Approve All Proposals at September 9, 2025 Special Meeting By More Than 75% In Favor - GlobeNewsWire
- 14 days ago - ProPhase Labs Inc. to Participate in Renmark's Virtual Non-Deal Roadshow Series on Thursday, September 4, 2025 - GlobeNewsWire
- 4 weeks ago - ProPhase Labs, Inc. (PRPH) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - ProPhase Labs Announces Filing of Definitive Proxy Statement and New Date for Special Meeting of Shareholders - GlobeNewsWire
- 5 weeks ago - ProPhase Labs Announces Financial Results for the Three and Six Months Ended June 30, 2025 - GlobeNewsWire
- 5 weeks ago - ProPhase Labs Announces Full USPTO Approval for Issuance of U.S. Patent Protecting Esophageal Adenocarcinoma Risk Assessment - GlobeNewsWire
- 5 weeks ago - ProPhase Labs Inc. to Present Second Quarter 2025 Financial Results on August 13, 2025 - GlobeNewsWire
- 7 weeks ago - ProPhase Labs Announces Special Meeting of Shareholders and Filing of Preliminary Proxy Statement - GlobeNewsWire